Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. 

Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.

Life Sciences

Isomorphic Labs

Demis Hassabis

Sergei Yakneen

Pamela Carroll

Miles Congreve

Max Jaderberg

Beverley Mallon

The Research and Development team at Isomorphic Labs is pioneering the integration of AI and computational methodologies into drug discovery. This team, composed of experts in machine learning, computational drug design, and cheminformatics, focuses on modeling the fundamental mechanisms of life to revolutionize the drug discovery process. They aim to accelerate scientific research and enhance the efficacy of new medicines, driving breakthroughs that will positively impact millions globally.

Research and Development

Engineering Team

Leadership Team

Research and Development

About

Team members

Other teams at Isomorphic Labs

Engineering Team

Leadership Team